Mechanistically, DGCR5 functions as a competing endogenous RNA (ceRNA) by competitively binding to tumor suppressor miR-3619-5p via activating MEK/ERK and JNK/p38 MAPK signaling pathways. Here, MAPK1 is linked to neoplasm.